Skip to main content

Qualifacts and MethodOne by Computalogic Partner to Elevate Controlled Medication Dispensing for Substance Use Disorders

In partnership with MethodOne by Computalogic

"We are excited to partner with Qualifacts to expand access to our comprehensive controlled medication dispensing solution," said Keith Jones, CEO of MethodOne by Computalogic. "Together, we are empowering SUD treatment providers to deliver high-quality care, improve operational efficiency, and ultimately save lives."
“We are excited to partner with Qualifacts to expand access to our comprehensive controlled medication dispensing solution,” said Keith Jones, CEO of MethodOne by Computalogic. “Together, we are empowering SUD treatment providers to deliver high-quality care, improve operational efficiency, and ultimately save lives.”

Nashville, Tenn., July 08, 2024 (GLOBE NEWSWIRE) — Qualifacts, the leading provider of end-to-end electronic health record (EHR) software and data solutions for behavioral healthcare organizations, and MethodOne by Computalogic, a comprehensive controlled-medication dispensing solution, announced a strategic partnership to address the escalating opioid epidemic. This collaboration integrates the award-winning EHR platforms from Qualifacts with MethodOne’s signature dispensing and inventory management functionality, providing a powerful and unified solution for substance use disorder (SUD) treatment providers.

The opioid crisis continues to devastate communities across the nation, with overdose deaths reaching alarming rates. Recognizing the urgent need for effective treatment solutions, Qualifacts and MethodOne have joined forces to empower providers with a comprehensive platform that streamlines workflows, enhances patient care, and optimizes revenue cycle management.

“Our partnership with MethodOne represents a significant step forward in the fight against the opioid epidemic,” said Josh Schoeller, CEO of Qualifacts. “By integrating our EHR platform with MethodOne’s robust controlled medication dispensing solution, we are providing addiction and SUD treatment providers with the tools they need to deliver comprehensive, evidence-based care and improve client outcomes.”

The Qualifacts-MethodOne integration offers a seamless, bi-directional flow of information between the EHR and MAT platforms, eliminating duplicative data entry and simplifying the entire controlled medication dispensing process. This streamlined approach enables providers to focus on delivering exceptional care while ensuring compliance with complex regulatory requirements.

“We are excited to partner with Qualifacts to expand access to our comprehensive controlled medication dispensing solution,” said Keith Jones, CEO of MethodOne by Computalogic. “Together, we are empowering SUD treatment providers to deliver high-quality care, improve operational efficiency, and ultimately save lives.”

ABOUT QUALIFACTS
Qualifacts is the leading provider of end-to-end EHR software and data solutions designed specifically for behavioral health, rehabilitative, and human services organizations. Our mission is to enhance the well-being of individuals and our communities and elevate the standard of care through innovative software and data solutions, including our award-winning EHRs Credible, CareLogic, and InSync. Over our nearly 25-year journey, Qualifacts has cultivated a loyal customer base of more than 3,000 organizations across all 50 states, including one-third of the nation’s Certified Community Behavioral Health Centers (CCBHCs). Non-profit and for-profit organizations, large and small, partner with Qualifacts to simplify workflows and improve clinical productivity, compliance and state reporting, revenue cycle management, business intelligence, client outcomes, and more.

Attachment

CONTACT: Tristan Galvan
Qualifacts
tristan.galvan@qualifacts.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.